Table 1.
Data of 447 melanoma patients from TCGA
| Characteristics | N | Percentages | Characteristics | N | Percentages |
|---|---|---|---|---|---|
| T | Clark level | ||||
| Ti | 7 | 1.75 | I/II/III | 98 | 31.72 |
| T1 | 41 | 10.28 | IV/V | 211 | 68.29 |
| T2 | 76 | 19.05 | Ulceration | ||
| T3 | 89 | 22.31 | No | 144 | 47.37 |
| T4 | 144 | 36.09 | Yes | 160 | 52.63 |
| N | Cancer status | ||||
| N0 | 222 | 59.04 | Tumor free | 210 | 49.64 |
| N1 | 73 | 19.41 | With tumor | 213 | 50.35 |
| N2 | 49 | 13.03 | New tumor event | ||
| M | No | 110 | 25.23 | ||
| M0 | 402 | 95.04 | Yes | 326 | 74.77 |
| M1 | 21 | 4.96 | Race | ||
| Stage | Asian | 11 | 2.51 | ||
| Stage0 | 6 | 1.49 | White | 427 | 97.49 |
| Stage1 | 76 | 18.81 | Age | ||
| Stage2 | 133 | 32.92 | < 60 | 237 | 53.02 |
| Stage3 | 169 | 41.83 | ≥ 60 | 210 | 46.98 |
| Stage4 | 20 | 4.95 | Site | ||
| – | – | – | Extremities | 191 | 49.35 |
| – | – | – | Head and neck | 32 | 8.27 |
| – | – | – | Trunk | 164 | 42.38 |
Patient characteristics included TNM stage, clinical stage, Clark level, ulceration, cancer status, new tumor event, race, age and site were identified